Coherus Oncology, Inc.

CHRS · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.3B · 147 employees
285
SEC Filings
$1.33
Close 2026-09-15
147
Employees

Business Summary

Coherus Oncology, Inc. (formerly Coherus BioSciences) is a commercial-stage immuno-oncology company. Its approved product LOQTORZI (toripalimab-tpzi), a PD-1 inhibitor, is FDA-approved for nasopharyngeal carcinoma (NPC). Its pipeline includes casdozokitug (CHS-388), an IL-27 antagonist antibody for hepatocellular carcinoma, and tagmokitug (CHS-114), a CCR8-targeting antibody for head and neck, GI, and colorectal cancers. The company commercializes LOQTORZI in the U.S. and holds global rights to its pipeline candidates.

Latest Stock Quote

CHRS 2026-09-15 $1.33 O:$1.38 H:$1.39 L:$1.32 Vol:0.8M VWAP:$1.3384
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-05

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-092025-12-310001104659-26-025308EDGAR91K words
2025-03-172024-12-310001558370-25-003126EDGAR109K words
2024-03-152023-12-310001558370-24-003436EDGAR108K words
2023-03-062022-12-310001558370-23-002917EDGAR—
2022-02-232021-12-310001558370-22-001764EDGAR—
2021-02-252020-12-310001558370-21-001829EDGAR—
2020-02-272019-12-310001564590-20-007416EDGAR—
2019-02-282018-12-310001564590-19-005470EDGAR—
2018-03-082017-12-310001564590-18-004947EDGAR—
2017-03-142016-12-310001564590-17-004176EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-052026-06-300001104659-26-091262EDGAR55K words
2025-11-062025-09-300001104659-25-107852EDGAR60K words
2025-08-072025-06-300001558370-25-010803EDGAR61K words
2025-05-122025-03-310001558370-25-007418EDGAR59K words
2024-11-062024-09-300001558370-24-014648EDGAR74K words
2024-08-082024-06-300001558370-24-011629EDGAR73K words
2024-05-092024-03-310001558370-24-007641EDGAR69K words
2023-11-062023-09-300001558370-23-017779EDGAR76K words
2023-08-022023-06-300001558370-23-012915EDGAR70K words
2023-05-082023-03-310001558370-23-008529EDGAR—
2022-11-082022-09-300001558370-22-016850EDGAR—
2022-08-042022-06-300001558370-22-012251EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-280001104659-26-103316EDGAR26K words
2026-08-170001104659-26-097951EDGAR11K words
2026-08-170001104659-26-097949EDGAR34K words
2026-08-050001104659-26-091188EDGAR4K words
2026-03-090001104659-26-025293EDGAR5K words
2026-02-170001104659-26-016378EDGAR22K words
2026-02-040001104659-26-010065EDGAR1K words
2026-01-230001104659-26-006307EDGAR1K words
2026-01-130001104659-26-003117EDGAR1K words
2025-11-130001104659-25-111484EDGAR40K words

285 total filings indexed. 253 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

nasopharyngeal-carcinoma-(npc) hepatocellular-carcinoma-(hcc) head-and-neck-squamous-cell-carcinoma-(hnscc) esophageal-squamous-cell-carcinoma-(escc) colorectal-cancer metastatic-castration-resistant-prostate-cancer-(mcrpc) immuno-oncology

Company Identity

CIK0001512762
TickerCHRS
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.coherus.com
Listed2014-11-06

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 511525aff0fea3e78c12717a27cb87dd04f695d4a98ab4a4c986488c120a4626
parent: 0812f80f5958bbc075b49038abb0473c548c4a6fd0c010fcb22a4847d1edbd04
content hash: f669b0d313a049b5e79612a43e6d619035904532d67fbebb6441bf54768911d8
signed: 2026-09-28T19:00:44.777Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up CHRS using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on CHRS, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/CHRS (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.